Free Anti-Trastuzumab
Detecting the development of Anti-drug antibodies (ADAs) against Trastuzumab in patients being treated with Trastuzumab
Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Trastuzumab can detect the presence of anti-drug antibodies against Trastuzumab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 10 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.
About Using Reagent
-
Sample Types
Serum, Whole blood -
Reaction Time
10 mins -
Detection Range
8-500 AU/mL -
Intended Use
Semi-quantitative determination of antibodies against Trastuzumab in human whole blood/serum
In Your Medical Field
AFIAS Free Anti-Trastuzumab detects anti-drug antibodies against Trastuzumab in just 10 minutes using a small amount of blood. It provides valuable insights into patients’ response to the treatment of Trastuzumab.